Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

ACC: Ablation Beats Amiodarone for Afib in HF

23.03.20151884
Catheter ablation of persistent atrial fibrillation (Afib) in patients with congestive heart failure (CHF) reduced arrhythmia recurrence compared with treatment with amiodarone.

Cardio Update Europe 2015 travel and participation grants for RSC members (Vienna, Austria, May 15-16, 2015)

23.03.20152574
Organizing Committee for conducting the Cardio Update Europe 2015 offers members of the Russian Society of Cardiology to take their chance and receive a grant to participate in the congress.

Four-factor prothrombin complex concentrate shows promise for urgent vitamin K antagonist reversal

19.03.20151609
Treatment with four-factor prothrombin complex concentrate was superior to plasma for the urgent reversal of vitamin K antagonist-induced anticoagulation prior to surgery, according to phase 3b study results.

Folic acid supplementation reduces stroke risk

18.03.20151800
Folic acid plus enalapril reduced the risk for first stroke compared with enalapril alone among adults with hypertension in China, according to data presented at the American College of Cardiology Scientific Sessions.

Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery

17.03.20151734
The benefit of early anticoagulation for stroke prophylaxis in atrial fibrillation after coronary artery bypass graft (CABG) surgery is uncertain.

Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus

16.03.20151978
The study aim to assess the effect of bB on the prognosis of heart failure (HF) patients with new–onset diabetes mellitus (DM) treated with a contemporary medical regime.

Patients with rheumatic autoimmune disease at higher risk after MI

13.03.20151637
The risk of mortality was higher in patients with rheumatic autoimmune diseases at 30 days and 12 months following myocardial infarction, and patients faced lower rates of revascularization, according to recently published research.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.